doi:10.1016/S0140-6736(24)01498-3 Perreault L, Davies M, Frias JP, et al
Portanto, pode ser um investimento desnecessrio
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
This powerful antioxidant has recently become a popular beauty treatment for skin lightening and treating severe skin diseases like atopic dermatitis, psoriasis, and eczema
Expected results and realistic timelines Setting realistic expectations is important for maintaining protocol adherence
Initially approved for managing Type 2 diabetes, semaglutide has also been shown to promote weight loss in certain doses, making it a popular choice for individuals seeking metabolic health benefits
